Kaigene is a biotechnology company that develops antibody therapeutics through research and preclinical studies.
Kaigene has raised $55.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2026.
Kaigene's investors include Sazze Partners.
Kaigene is headquartered in Rockville, United States.
Kaigene is a biotechnology company that develops antibody therapeutics through research and preclinical studies.
Kaigene is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kaigene — Funding & Investors." VCBacked, October 14, 2026, https://www.vcbacked.co/company/kaigene. Accessed November 5, 2026.
VCBacked. (2026). Kaigene — Funding & Investors. Retrieved November 5, 2026, from https://www.vcbacked.co/company/kaigene
{{cite web |title=Kaigene — Funding & Investors |url=https://www.vcbacked.co/company/kaigene |website=VCBacked |access-date=November 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Kaigene? Request a listing update